TrialGenome medicine2020

CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial.

Ming-Ci Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.